Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jemma C Hopewell

Showing results (11-20 of 85) with videos related to

Pageof 9
Sort By:
Neurology|February 22, 2019
Relative effects of LDL-C on ischemic stroke and coronary disease: A Mendelian randomization studyElsa Valdes-Marquez, Sarah Parish, Robert Clarke, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 14, 2014
A common LPA null allele associates with lower lipoprotein(a) levels and coronary artery disease riskTheodosios Kyriakou, Udo Seedorf, Anuj Goel, et al.
Physiological Measurement|January 25, 2020
Identification of patients with atrial fibrillation: a big data exploratory analysis of the UK BiobankJulien Oster, Jemma C Hopewell, Klemen Ziberna, et al.
Brain : a Journal of Neurology|January 23, 2020
Genetic determinants of blood lipids and cerebral small vessel disease: role of high-density lipoprotein cholesterolMarios K Georgakis, Rainer Malik, Christopher D Anderson, et al.
Journal of the American College of Cardiology|April 5, 2011
No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the heart protection studyJemma C Hopewell, Sarah Parish, Robert Clarke, et al.
European Heart Journal|October 27, 2012
Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection StudyJemma C Hopewell, Sarah Parish, Alison Offer, et al.
Heart (British Cardiac Society)|February 26, 2025
Balancing the risk of major bleeding against vascular disease risk in people without atherosclerotic diseaseImen Hammami, Marion Mafham, Jonathan Emberson, et al.
Communications Medicine|July 3, 2026
Integrative proteogenomic analyses identify plasma proteins that impact the risk of ischemic strokeLazaros Belbasis, Adam von Ende, Parag Gajendragadkar, et al.
Open Heart|May 2, 2018
Plasma cytokines and risk of coronary heart disease in the PROCARDIS studyRobert Clarke, Elsa Valdes-Marquez, Michael Hill, et al.
Clinical Therapeutics|August 27, 2019
Serious Adverse Effects of Extended-release Niacin/Laropiprant: Results From the Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE) TrialRichard Haynes, Elsa Valdes-Marquez, Jemma C Hopewell, et al.
Pageof 9

Showing results (11-20 of 85) with videos related to

Sort By:
Pageof 9
Neurology|February 22, 2019
Relative effects of LDL-C on ischemic stroke and coronary disease: A Mendelian randomization studyElsa Valdes-Marquez, Sarah Parish, Robert Clarke, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 14, 2014
A common LPA null allele associates with lower lipoprotein(a) levels and coronary artery disease riskTheodosios Kyriakou, Udo Seedorf, Anuj Goel, et al.
Physiological Measurement|January 25, 2020
Identification of patients with atrial fibrillation: a big data exploratory analysis of the UK BiobankJulien Oster, Jemma C Hopewell, Klemen Ziberna, et al.
Brain : a Journal of Neurology|January 23, 2020
Genetic determinants of blood lipids and cerebral small vessel disease: role of high-density lipoprotein cholesterolMarios K Georgakis, Rainer Malik, Christopher D Anderson, et al.
Journal of the American College of Cardiology|April 5, 2011
No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the heart protection studyJemma C Hopewell, Sarah Parish, Robert Clarke, et al.
European Heart Journal|October 27, 2012
Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection StudyJemma C Hopewell, Sarah Parish, Alison Offer, et al.
Heart (British Cardiac Society)|February 26, 2025
Balancing the risk of major bleeding against vascular disease risk in people without atherosclerotic diseaseImen Hammami, Marion Mafham, Jonathan Emberson, et al.
Communications Medicine|July 3, 2026
Integrative proteogenomic analyses identify plasma proteins that impact the risk of ischemic strokeLazaros Belbasis, Adam von Ende, Parag Gajendragadkar, et al.
Open Heart|May 2, 2018
Plasma cytokines and risk of coronary heart disease in the PROCARDIS studyRobert Clarke, Elsa Valdes-Marquez, Michael Hill, et al.
Clinical Therapeutics|August 27, 2019
Serious Adverse Effects of Extended-release Niacin/Laropiprant: Results From the Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE) TrialRichard Haynes, Elsa Valdes-Marquez, Jemma C Hopewell, et al.
Pageof 9